Skip navigation |

Blue September

Blue September UK

Blue September UK is the first national cancer awareness campaign aimed at men which covers all the cancers that can affect them. Launched this year, it will be an annual event with a focus on prevention, symptom awareness and early diagnosis. The campaign is needed because men are 40% more likely than women to die from cancer, and 70% more likely to die from a non-sex-specific cancer.

Blue September UK has a major charity partner, the Men's Health Forum, which will benefit from the funds raised and is also supported by the organisations shown below.

BAUS logo

Bayer Pharmaceuticals

Bristol-Myers Squibb

Constructing Better Health

Intuitive Surgical

Everton FC

Fulham FC

Healthy Stadia

Liverpool FC

NHS Direct

Portsmouth FC

Premier League football

Roche Pharmaceuticals

Royal College of General Practitioners

Royal College of Nursing

Royal Pharmaceutical Society

Tottenham Hotspur FC

Varian Medical Systems

Blue September UK receives additional support from national cancer director Professor Sir Mike Richards, from Care Services Minister Paul Burstow MP and from many other organisations and individuals. See their statements on the Blue September UK website.

Mr Adrian Joyce, President of BAUS, says:

"BAUS strongly supports the Blue September awareness campaign to highlight the issues relating to men and the development of cancer. BAUS encourages men to seek early diagnosis of their symptoms, which offers the greatest opportunity for cure, and to understand, and know all their treatment options. Action is needed to highlight all aspects of Urological Cancer development which may affect men, including prevention, and BAUS supports the work of the Men's Health Forum in seeking to address these issues through Blue September."

If BAUS members wish to contribute to the campaign by, for example, meeting patients or staff, organising a media call, hosting a hospital event or even offering themselves for an "expert talk", please contact Blue September UK by e-mail.